Active Surveillance: The Sweet Smell of Success in Sweden
October 30 @ 12:00 pm - 1:30 pm EDT
Dr. Ola Bratt is one of the leading urologists in Sweden helping men navigate AS. His successful approaches to navigating AS will be shared.
Only 55% of American patients with low-risk prostate cancer go on active surveillance, UCSF researchers reported recently.
Ten years ago, only 6% of of these men went on AS. In contrast, the rate is above 90% in Sweden, according to Ola Bratt, MD, a prominent Swedish urologist.
Dr. Bratt is a consultant urological surgeon at the Prostate Cancer Centre, Sahlgrenska University Hospital Gothenburg, Sweden. He is Chairman of the National Prostate Cancer Guidelines Group in Sweden.
Clinical management and epidemiology of prostate cancer has been the clinical and research focus since Dr. Bratt started his urological career in the early 1990s. He defended his PhD thesis “Familial and Hereditary Prostate Cancer” in 1999 and became Associate Professor of Urology at Lund University in 2003. He has now published over 100 scientific articles on prostate cancer.
As many years chairman of the Swedish National Prostate Cancer Guidelines Group Dr. Bratt also chairs the committee preparing for a national screening programme for prostate cancer. He is principal investigator of a randomised multicentre trial for men on active surveillance for prostate cancer and investigator of several other clinical trials.